News
No news
It seems that there is no news published yet.
-
Multitude SE announces its intention to voluntarily redeem all outstanding senior bonds due 2025
-
Formycon starts clinical development program for FYB206, a biosimilar candidate for immuno-oncology blockbuster drug Keytruda
-
CFO Andrea Borla to leave LEM by end of November 2024
-
Multitude Capital Oyj successfully places EUR 80 million in senior guaranteed unsecured bonds
-
Ørsted completes construction of combined wind and solar project in Texas
-
imerys-12-06-2024-implementation-of-the-share-buyback-program
-
COGELEC : Statement on the total number of shares and voting rights.
-
Biophytis announces the successful industrial transfer of BIO101 (20-hydroxyecdysone) production by its service provider Seqens
-
ALTEN enters into exclusive negociations with ATOS for the acquisition of Worldgrid
-
Disclosure of trading in own shares from Jun 3rd, 2024, to Jun 7th, 2024. Detailed information per transaction